Endogenous fibroblast growth factor-2 mediates cytotoxicity in experimental mesangioproliferative glomerulonephritis

Journal of the American Society of Nephrology

Volumn 9, Issue 5, 1998, Pages 792-801

  Floege, Jürgen ^a   Burg, Michael ^a   Hugo, Christian ^b   Gordon, Katherine L ^b   Van Goor, Harry ^d   Reidy, Michael ^c   Couser, William G ^b   Koch, Karl Martin ^a   Johnson, Richard J ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CYTOPATHOGENIC EFFECT; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

EID: 0031970626     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Slomowitz LA, Klahr S, Schreiner GF, Ichikawa I: Progression of renal disease. N Engl J Med 319: 1547-1548, 1988
2. Striker LJ, Peten EP, Elliot SJ, Doi T, Striker GE: Mesangial cell turnover: Effect of heparin and peptide growth factors. Lab Invest 64: 446-456, 1991
3. Monta T, Churg J: Mesangiolysis. Kidney Int 24: 1-9, 1983
4. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritz P, Gordon K, Seifert RA, Bowen Pope DF, Couser WG, Johnson RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41: 297-309, 1992
5. Pesce CM, Striker LJ, Peten EP, Elliot SJ, Striker GE: Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 65: 601-605, 1991
6. Klagsbrun M, Edelman ER: Biological and biochemical properties of fibroblast growth factors: Implications for the pathogenesis of atherosclerosis. Arteriosclerosis 9: 269-278, 1989
7. Baird A, Walicke PA: Fibroblast growth factors. Br Med Bull 45: 438-452, 1989
8. Floege J, Eng E, Lindner V, Alpers CE, Young BA, Reidy MA, Johnson RJ: Rat glomerular mesangial cells synthesize basic fibroblast growth factor: Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest 90: 2362-2369, 1992
9. D'Amore PA: Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev 9: 227-238, 1990
10. Francki A, Uciechowski P, Floege J, Von der Ohe J, Resch K, Radeke HH: Autocrine growth regulation of human glomerular mesangial cells is primarily mediated by basic fibroblast growth factor. Am J Pathol 147: 1372-1382, 1995
11. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen Pope DF, Johnson RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92: 2952-2962, 1993
12. Floege J, Kriz W, Schulze M, Susani M, Kerjaschki D, Mooney A, Couser WG, Koch KM: Basic FGF (FGF-2) augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Clin Invest 96: 2809-2819, 1995
13. 2 and prostacyclin. Kidney Int 38: 232-239, 1990
14. Silver BJ, Jaffer FE, Abboud HE: Platelet-derived growth factor synthesis in mesangial cells: Induction by multiple peptide mitogens. Proc Natl Acad Sci USA 86: 1056-1060, 1989
15. Ballermann BJ: Regulation of bovine glomerular endothelial cell growth in vitro. Am J Physiol 256: C182-C189, 1989
16. Shankland SJ, Floege J, Thomas SE, Nangaku M, Pippin J, Henne K, Hockenberry D, Johnson RJ, Couser WG: Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 52: 404-413, 1997
17. Johnson RJ, Garcia RL, Pritzl P, Alpers CE: Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 136: 369-374, 1990
18. Johnson RJ, Iida H, Alpers CE, Majesky MW. Schwartz SM, Pritzl P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87: 847-858, 1991
19. Lindner V, Reidy MA: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 88: 3739-3743, 1991
20. Yayon A, Aviezer D, Safran M, Gross JL, Heldman Y, Cabilly S, Givol D, Katchalski-Katzir E: Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proc Natl Acad Sci USA 90: 10643-10647, 1993
21. Burg M, Ostendorf T, Mooney A, Koch KM, Floege J: Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: Therapeutic efficacy and safety. Lab Invest 76: 505-516, 1997
22. Hunter WM, Greenwood FC: Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194: 495-496, 1962
23. Johnson RJ, Couser WG, Chi EY, Adler S, Klebanoff SJ: New mechanism for glomerular injury: Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 79: 1379-1387, 1987
24. Bieber F: Biotinylierung monoklonaler Antikörper. In: Monoklonale Antikörper. Herstellung und Charakterisierung, edited by Peters H, Berlin, Springer, 1985, pp 209-212
25. Schulze M, Baker PJ, Perkinson DT, Johnson RJ, Ochi RF, Stahl RAK, Couser WG: Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int 35: 60-68, 1989
26. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G: A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103: 2787-2796, 1986
27. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19: 464-474, 1992
28. Dijkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54: 589-599, 1985
29. Bagchus WM, Jeunink MF, Rozing J, Elema JD: A monoclonal antibody against rat platelets: Tissue distribution in vitro and in vivo. Clin Exp Immunol 75: 317-323, 1989
30. Fouser L, Iruela-Arispe L, Bornstein P, Sage EH: Transcriptional activity of the alpha 1(I)-collagen promoter is correlated with the formation of capillary-like structures by endothelial cells in vitro. J Biol Chem 266: 18345-18351, 1991
31. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J: Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 49: 666-678, 1996
32. Hugo C, Pichler R, Gordon K, Schmidt R, Amieva M, Couser WG, Furthmayr H, Johnson RJ: The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis. J Clin Invest 97: 2499-2508, 1996
33. Poelstra K, Hardonk MJ, Koudstaal J, Bakker WW: Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int 37: 1500-1508, 1990
34. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94: 2105-2116, 1994
35. Verdon CP, Burton BA, Prior RL: Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP when the Griess reaction is used to assay for nitrite. Anal Biochem 224: 502-508, 1995
36. Johnson RJ, Alpers CE, Pritzl P, Schulze M, Baker P, Pruchno C, Couser WG: Platelets mediate neutrophil dependent immune complex nephritis in the rat. J Clin Invest 82: 1225-1235, 1988
37. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40: 477-488, 1991
38. Floege J, Eng E, Young BA, Couser WG, Johnson RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43: 369-380, 1993
39. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175: 1413-1416, 1992
40. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G: Hypotensive activity of fibroblast growth factor. Science 254: 1208-1210, 1991
41. Kiyama S, Nanishi F, Tomooka S, Okuda S, Onoyama K, Fujishima M: Inhibitory effect of antihypertensive drugs on mesangial cell proliferation after anti-thymocyte serum-induced mesangiolysis in spontaneously hypertensive rats. Life Sci 54: 1891-1900, 1994
42. Yamamoto T, Mundy CA, Wilson CB, Blantz RC: Effect of mesangial cell lysis and proliferation on glomerular hemodynamics in the rat. Kidney Int 40: 705-713, 1991
43. Narita I, Border WA, Ketteler M, Noble NA: Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 72: 17-24, 1995
44. Pfeilschifter J: Does nitric oxide, an inflammatory mediator of glomerular mesangial cells, have a role in diabetic nephropathy? Kidney Int 48[Suppl 51]: S50-S60, 1995
45. Lo YYC, Cruz TF: Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 270: 11727-11730, 1995
46. Estevez AG, Radi R, Barbeito L, Shin JT, Thompson JA, Beckmann JS: Peroxynitrite-induced cytotoxicity in PC12 cells: Evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem 65: 1543-1550, 1995